Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation

[1]  N. Ahn,et al.  Feedback Regulation of Raf-1 and Mitogen-activated Protein Kinase (MAP) Kinase Kinases 1 and 2 by MAP Kinase Phosphatase-1 (MKP-1)* , 1998, The Journal of Biological Chemistry.

[2]  A. Burnett,et al.  Mutant N-RAS Induces Erythroid Lineage Dysplasia in Human CD34+ Cells , 1997, The Journal of experimental medicine.

[3]  H. Saito,et al.  Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells , 1997, Leukemia.

[4]  野本 周嗣.  Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma , 1997 .

[5]  P. Tsichlis,et al.  Akt Is a Direct Target of the Phosphatidylinositol 3-Kinase , 1996, The Journal of Biological Chemistry.

[6]  M. Symons,et al.  Rho family GTPases: the cytoskeleton and beyond. , 1996, Trends in biochemical sciences.

[7]  M. Collins,et al.  The role of MAP kinase kinase in interleukin-3 stimulation of proliferation. , 1996, Blood.

[8]  A. Nakao,et al.  Detection of Hepatic Micrometastasis in Pancreatic Adenocarcinoma Patients by Two‐stage Polymerase Chain Reaction/Restriction Fragment Length Polymorphism Analysis , 1995, Japanese journal of cancer research : Gann.

[9]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[10]  T. Enver,et al.  Regulation of GATA-2 Phosphorylation by Mitogen-activated Protein Kinase and Interleukin-3 (*) , 1995, The Journal of Biological Chemistry.

[11]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[12]  N. Russell,et al.  Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. , 1994, Experimental hematology.

[13]  C. Marshall,et al.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.

[14]  C. Bloomfield,et al.  Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia , 1994 .

[15]  C. Marshall,et al.  MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. , 1994, Current opinion in genetics & development.

[16]  J. Blenis,et al.  Signal transduction via the MAP kinases: proceed at your own RSK. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Guan,et al.  Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. , 1993, The Journal of biological chemistry.

[18]  E. Nishida,et al.  The MAP kinase cascade is essential for diverse signal transduction pathways. , 1993, Trends in biochemical sciences.

[19]  T. Naoe,et al.  Clonal Analysis of Multiple Point Mutations in the N‐ras Gene in Patients with Acute Myeloid Leukemia , 1993, Japanese journal of cancer research : Gann.

[20]  H. Michel,et al.  Molecular structure of a protein-tyrosine/threonine kinase activating p42 mitogen-activated protein (MAP) kinase: MAP kinase kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Crews,et al.  The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. , 1992, Science.

[22]  V. Duronio,et al.  Multiple hemopoietic growth factors stimulate activation of mitogen-activated protein kinase family members. , 1992, Journal of immunology.

[23]  S. Pelech,et al.  Mitogen-activated protein kinases: versatile transducers for cell signaling. , 1992, Trends in biochemical sciences.

[24]  M. Hallek,et al.  Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. , 1992, Blood.

[25]  C. Koh,et al.  Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes. , 1992, Singapore medical journal.

[26]  J. Radich,et al.  N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. , 1990, Blood.

[27]  M. Bar‐eli,et al.  The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. , 1990, Blood.

[28]  J. Maller,et al.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase , 1990, Nature.

[29]  H. Kantarjian,et al.  Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia. , 1989, Blood.

[30]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[31]  H. Mano,et al.  A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome , 1987, Nature.